Metformin Interactions
Metformin Interactions is a pharmacological construct that denotes the biochemical and physiological alterations in metformin's efficacy or safety profile resulting from its co-administration with other drugs, herbal products, or endogenous substances, particularly within the context of glucose metabolism and renal excretion pathways.
136
Publications
5.3K
Citations
861
Authors
314
Institutions
Publications per year
2017–2026
65
Variants
Metformin Drug Interactions
Parents
136
Hiroyuki Kusuhara, S Ito, Yoshito Kumagai et al. · Clinical Pharmacology & Therapeutics · 2011 · 215 citations
Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)
Anne T. Nies, Ute Hofmann, Claudia Resch et al. · PLoS ONE · 2011 · 186 citations · Full text
1–5 of 136
861
Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany
4 publications · 315 citations
4
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 861
314
Friedrich-Alexander-Universität Erlangen-Nürnberg
Erlangen, Germany
5 h-index
12 publications
1K citations
GlaxoSmithKline (United States)
Philadelphia, United States
5 h-index
20 publications
1.2K citations

Seoul National University Hospital
Seoul, South Korea
4 h-index
29 publications
548 citations
Novartis (Switzerland)
Basel, Switzerland
3 h-index
24 publications
786 citations
Boehringer Ingelheim (Germany)
Ingelheim, Germany
3 h-index
19 publications
927 citations
Seoul National University
Seoul, South Korea
3 h-index
9 publications
252 citations

The University of Texas at San Antonio Health Science Center
San Antonio, United States
3 h-index
7 publications
99 citations

University of Cagliari
Cagliari, Italy
3 h-index
11 publications
333 citations
1–8 of 314
5 publications · 87 citations
5
h-index
CPT · 4 publications · 307 citations
4
h-index
4 publications · 118 citations
4
h-index
4 publications · 477 citations
4
h-index
CPDD · 4 publications · 87 citations
4
h-index
1–5